iomeprol has been researched along with Kidney Diseases in 18 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine is a crucial mediator of contrast-induced nephropathy (CIN; an increase in serum creatinine of >or=0." | 2.71 | Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. ( Classen, M; Hennig, M; Huber, W; Ilgmann, K; Lutilsky, L; Page, M; Schipek, C; Schömig, A; Schweigart, U; Seyfarth, M; Valina, C; Wacker, A, 2003) |
| "Iomeprol is a new nonionic monomeric contrast medium which has been tested during preclinical studies and clinical trials." | 2.39 | Safety profile of new non-ionic contrast media: renal tolerance. ( Stacul, F; Thomsen, HS, 1996) |
| "Curcumin (CC) is a natural substance with strong antioxidant efficacy." | 1.40 | Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis? ( Bakirci, EM; Buyuklu, M; Kandemir, FM; Ozkaraca, M; Set, T; Topal, E, 2014) |
| "Lung cancer is treatable with platinum-based cytostatic drugs, which can be nephrotoxic." | 1.35 | [Delay in implementation of international guidelines for computed tomographies with iodinated contrast media]. ( Holländer, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyuklu, M | 1 |
| Kandemir, FM | 1 |
| Ozkaraca, M | 1 |
| Set, T | 1 |
| Bakirci, EM | 1 |
| Topal, E | 1 |
| Azzouz, M | 1 |
| Rømsing, J | 1 |
| Thomsen, HS | 3 |
| Schabel, C | 1 |
| Bongers, M | 1 |
| Sedlmair, M | 1 |
| Korn, A | 1 |
| Grosse, U | 1 |
| Mangold, S | 1 |
| Claussen, CD | 1 |
| Thomas, C | 1 |
| Morcos, SK | 1 |
| Heng, AE | 1 |
| Cellarier, E | 1 |
| Aublet-Cuvelier, B | 1 |
| Decalf, V | 1 |
| Motreff, P | 1 |
| Marcaggi, X | 1 |
| Deteix, P | 1 |
| Souweine, B | 1 |
| Holländer, C | 1 |
| Alexopoulos, E | 1 |
| Spargias, K | 1 |
| Kyrzopoulos, S | 1 |
| Manginas, A | 1 |
| Pavlides, G | 1 |
| Voudris, V | 1 |
| Lerakis, S | 1 |
| McLean, DS | 1 |
| Cokkinos, DV | 1 |
| Wessely, R | 1 |
| Koppara, T | 1 |
| Bradaric, C | 1 |
| Vorpahl, M | 1 |
| Braun, S | 1 |
| Schulz, S | 1 |
| Mehilli, J | 1 |
| Schömig, A | 2 |
| Kastrati, A | 1 |
| Marraccini, P | 1 |
| Bianchi, M | 1 |
| Fommei, E | 1 |
| Palmieri, C | 1 |
| Ciriello, G | 1 |
| Ciardetti, M | 1 |
| Mazzarisi, A | 1 |
| Djukic, G | 1 |
| L'Abbate, A | 1 |
| Kim, KS | 1 |
| Kim, K | 1 |
| Hwang, SS | 1 |
| Jo, YH | 1 |
| Lee, CC | 1 |
| Kim, TY | 1 |
| Rhee, JE | 1 |
| Suh, GJ | 1 |
| Singer, AJ | 1 |
| Kim, HD | 1 |
| Song, KD | 1 |
| Kim, CK | 1 |
| Park, BK | 1 |
| Kim, B | 1 |
| Erselcan, T | 1 |
| Egilmez, H | 1 |
| Hasbek, Z | 1 |
| Tandogan, I | 1 |
| Balemans, CE | 1 |
| Reichert, LJ | 1 |
| van Schelven, BI | 1 |
| van den Brand, JA | 1 |
| Wetzels, JF | 1 |
| Inci, MF | 1 |
| Salk, I | 1 |
| Solak, O | 1 |
| Vurdem, UE | 1 |
| Inci, R | 1 |
| Lacquaniti, A | 1 |
| Buemi, F | 1 |
| Lupica, R | 1 |
| Giardina, C | 1 |
| Murè, G | 1 |
| Arena, A | 1 |
| Visalli, C | 1 |
| Baldari, S | 1 |
| Aloisi, C | 1 |
| Buemi, M | 1 |
| Huber, W | 2 |
| Schipek, C | 1 |
| Ilgmann, K | 1 |
| Page, M | 1 |
| Hennig, M | 2 |
| Wacker, A | 2 |
| Schweigart, U | 1 |
| Lutilsky, L | 1 |
| Valina, C | 1 |
| Seyfarth, M | 1 |
| Classen, M | 1 |
| Eckel, F | 1 |
| Rosenbrock, H | 1 |
| Saur, D | 1 |
| Sennefelder, A | 1 |
| Hennico, R | 1 |
| Schenk, C | 1 |
| Meining, A | 1 |
| Schmelz, R | 1 |
| Fritsch, R | 1 |
| Weiss, W | 1 |
| Hamar, P | 1 |
| Heemann, U | 1 |
| Schmid, RM | 1 |
| Stacul, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Clinical Trial to Investigate Adverse Reactions to MR and CT-examinations (Enhanced and Unenhanced)[NCT01132339] | 1,467 participants (Actual) | Observational | 2010-05-31 | Completed | |||
| Prospective, Randomized, Comparative Study to Evaluate the Effect of Iodixanol 320 Compared to Iomeprol 350 on Contrast Medium Induced Nephropathy in Patients With Impaired Renal Function Undergoing PCI[NCT00390585] | Phase 4 | 324 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Chinese People's Liberation Army General Hospital[NCT02718521] | 400 participants (Anticipated) | Interventional | 2016-03-31 | Active, not recruiting | |||
| Chinese People's Liberation Army General Hospital[NCT02405377] | 264 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for iomeprol and Kidney Diseases
| Article | Year |
|---|---|
Safety profile of new non-ionic contrast media: renal tolerance.
Topics: Animals; Contrast Media; Humans; Iopamidol; Kidney; Kidney Diseases; Osmolar Concentration; Randomiz | 1996 |
8 trials available for iomeprol and Kidney Diseases
| Article | Year |
|---|---|
Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Artifacts; Contrast Media; Denmark; Fem | 2014 |
Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Topics: Aged; Contrast Media; Dimerization; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Iopa | 2009 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; D | 2008 |
Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Topics: Acute Disease; Aged; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Humans; Iopami | 2010 |
Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Medi | 2009 |
Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; | 2013 |
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
Topics: Adenosine; Aged; Contrast Media; Coronary Angiography; Creatinine; Endpoint Determination; Female; H | 2003 |
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Contrast Media; Creatinine; Cri | 2006 |
9 other studies available for iomeprol and Kidney Diseases
| Article | Year |
|---|---|
Protective effect of curcumin against contrast induced nephropathy in rat kidney: what is happening to oxidative stress, inflammation, autophagy and apoptosis?
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Autophagy; Biomarkers; Contrast Media; C | 2014 |
Assessment of the hepatic veins in poor contrast conditions using dual energy CT: evaluation of a novel monoenergetic extrapolation software algorithm.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Female; Hepatic Veins; Humans; Image Enh | 2014 |
[Delay in implementation of international guidelines for computed tomographies with iodinated contrast media].
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Contrast Media; Creatinine; Guideline Adherence; Huma | 2009 |
Contrast medium nephrotoxicity after renal artery and coronary angioplasty.
Topics: Aged; Angioplasty; Angioplasty, Balloon, Coronary; Case-Control Studies; Chi-Square Distribution; Co | 2010 |
Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Emergency Service, Hospital; Female; Hum | 2011 |
Utility of iodine overlay technique and virtual unenhanced images for the characterization of renal masses by dual-energy CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Female; Humans; Iopamidol; K | 2011 |
Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
Topics: Blood Urea Nitrogen; Contrast Media; Creatinine; Female; Glomerular Filtration Rate; Humans; Inpatie | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
Epidemiology of contrast material-induced nephropathy in the era of hydration.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Iohexol; Iopamidol; Kid | 2012 |
[ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
Topics: Acetylcysteine; Animals; Antioxidants; Arterioles; Contrast Media; Drug Evaluation, Preclinical; Iop | 2012 |